Search research articles
Contact Us
Filters
Showing results (131-140 of 141) with videos related to
Page
of 15
Sort By:
Structure (London, England : 1993)
|
April 5, 2016
Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region
William D Tolbert, Neelakshi Gohain, Maxime Veillette, et al.
NPJ Vaccines
|
February 9, 2021
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
Thomas W Geisbert, Kathryn Bobb, Viktoriya Borisevich, et al.
The Journal of Infectious Diseases
|
October 21, 1998
Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection
L D Loomis-Price, J H Cox, J R Mascola, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor
J H Fleisch, C T Armstrong, C R Roman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 15, 2012
Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding
Yongjun Guan, Marzena Pazgier, Mohammad M Sajadi, et al.
The Journal of Infectious Diseases
|
April 1, 1994
Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans
C Gonzalez, D Hone, F R Noriega, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 17, 2016
Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach
Christopher B Fox, Mark T Orr, Neal Van Hoeven, et al.
Cell Reports
|
April 7, 2015
NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer
Collin M Blakely, Evangelos Pazarentzos, Victor Olivas, et al.
Molecular Systems Biology
|
May 4, 2019
Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protection
Srivamshi Pittala, Kenneth Bagley, Jennifer A Schwartz, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2015
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection
Timothy R Fouts, Kenneth Bagley, Ilia J Prado, et al.
Page
of 15
Search research articles
Search
Showing results (131-140 of 141) with videos related to
Sort By:
Page
of 15
Structure (London, England : 1993)
|
April 5, 2016
Paring Down HIV Env: Design and Crystal Structure of a Stabilized Inner Domain of HIV-1 gp120 Displaying a Major ADCC Target of the A32 Region
William D Tolbert, Neelakshi Gohain, Maxime Veillette, et al.
NPJ Vaccines
|
February 9, 2021
A single dose investigational subunit vaccine for human use against Nipah virus and Hendra virus
Thomas W Geisbert, Kathryn Bobb, Viktoriya Borisevich, et al.
The Journal of Infectious Diseases
|
October 21, 1998
Correlation between humoral responses to human immunodeficiency virus type 1 envelope and disease progression in early-stage infection
L D Loomis-Price, J H Cox, J R Mascola, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
July 1, 1996
Recombinant human secretory phospholipase A2 released thromboxane from guinea pig bronchoalveolar lavage cells: in vitro and ex vivo evaluation of a novel secretory phospholipase A2 inhibitor
J H Fleisch, C T Armstrong, C R Roman, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 15, 2012
Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding
Yongjun Guan, Marzena Pazgier, Mohammad M Sajadi, et al.
The Journal of Infectious Diseases
|
April 1, 1994
Salmonella typhi vaccine strain CVD 908 expressing the circumsporozoite protein of Plasmodium falciparum: strain construction and safety and immunogenicity in humans
C Gonzalez, D Hone, F R Noriega, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
November 17, 2016
Adsorption of a synthetic TLR7/8 ligand to aluminum oxyhydroxide for enhanced vaccine adjuvant activity: A formulation approach
Christopher B Fox, Mark T Orr, Neal Van Hoeven, et al.
Cell Reports
|
April 7, 2015
NF-κB-activating complex engaged in response to EGFR oncogene inhibition drives tumor cell survival and residual disease in lung cancer
Collin M Blakely, Evangelos Pazarentzos, Victor Olivas, et al.
Molecular Systems Biology
|
May 4, 2019
Antibody Fab-Fc properties outperform titer in predictive models of SIV vaccine-induced protection
Srivamshi Pittala, Kenneth Bagley, Jennifer A Schwartz, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 15, 2015
Balance of cellular and humoral immunity determines the level of protection by HIV vaccines in rhesus macaque models of HIV infection
Timothy R Fouts, Kenneth Bagley, Ilia J Prado, et al.
Page
of 15